Person:
BECEREN, AYFER

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

BECEREN

First Name

AYFER

Name

Filters

2022 - 20233
Reset filters

Settings

Has files: true × Subject: Health Sciences ×

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationOpen Access
    Safety of herbal drugs
    (2023-01-01) BECEREN, AYFER; BECEREN A.
  • Thumbnail Image
    PublicationOpen Access
    Evaluation of clinical pharmacist interventions on drug-related problems in the gastroenterology ward
    (2022-01-01) SANCAR, MESUT; BECEREN, AYFER; CEYLAN C., SANCAR M., BECEREN A., Demir A., KUŞ C., Omurtag G. Z.
    Integrating clinical pharmacists in a multidisciplinary patient care team improves the treatment process by identifying and resolving drug-related problems (DRPs). The aim of the study was to determine the effect of clinical pharmacist intervention for DRPs in the gastroenterology service. The first period of the study was conducted between 15.06.2018 and 15.02.2019. Eighty patients admitted to the gastroenterology ward, who used at least one medication, were included in \"the study group\". The clinical pharmacist participated in ward rounds and made interventions to solve identified DRPs. In the second period of the study, the control group consisted of 80 patients admitted to the same ward between 01.03.2019 and 06.06.2019. DRPs were determined only from the data obtained from the hospital system in the control group. DRPs were classified according to the European Pharmaceutical Care Network (PCNE V9.1). A total of 136 and 46 with an average of 1.7 and 0.57 DRPs per patient (p <= 0.01) were identified in the study and control groups, respectively. Of the DRPs in the study group, 59 were related to treatment effectiveness, while 61 were related to treatment safety. Likewise, 21 DRPs were related to treatment effectiveness in the control group, while 12 were related to treatment (p <= 0.01). 65% of the interventions were made at the physician level and 49% at the drug level. 97% (n=133) of the total interventions were accepted. The number of DRPs was significantly reduced in the control group within the time frame after the clinical pharmacist intervention period. In conclusion, clinical pharmacists\" importance in detecting and preventing DRPs in the gastroenterology ward has been demonstrated.
  • Thumbnail Image
    PublicationOpen Access
    Determination of in vitro genotoxic effects of pine resin and Aronia melonacarpa on prostate and breast cancer cell lines by using comet assay technique
    (2022-11-05) BECEREN, AYFER; BİNGÖL ÖZAKPINAR, ÖZLEM; Beceren A., Bingöl Özakpınar Ö.
    The cancer burden continues to grow globally and places extraordinary physical, emotional and financial pressures on individuals, communities and health systems. Studies continue without slowing down to establish new targets and treatment strategies for cancer, which still remains an important problem in the clinic and does not have a definitive cure yet. Natural compounds obtained from different sources stand out as new therapeutic agents in cancer due to their more effective and selective properties and lower toxic effects. Thus, we aimed to clarify the possible anticancer effects of Aronia melonacarpa on human breast cancer cell line (MCF-7) and pine resinon prostate cancer cell line (PC-3).Our target plants, pine resin and Aronia melonacarpa were collected from different locations from Aegean and Blacksea region of Türkiye, respectively. The genotoxic effect of the methanol extracts was determined by alkaline comet assay. 100, 200 and 400 μg/ml extract concentrations, which have the high cytotoxic effect, were used. The examined groups were control negative, plant extract and positive control groups. Comparison of the anti-cancer and genotoxic effect of different concentrations on MCF-7 of Aronia melonacarpa and pine resin on PC-3 was evaluated by SPSS 20.0 program. Comet assay results showed that the both Aronia melonacarpa and pine resin extract exhibited genotoxic effects against MCF-7 and PC-3 cell lines in a dose-dependent manner by increasing the mean percentage of DNA damage after 24hrs of treatment (p<0.001).However, the observed toxicity of this two plant extract needs to be confirmed by additional studies. Based on our results, further examination of the potential anticancer properties of two plant species and the identification of the active ingredients of these extracts is warranted. This preliminary study is important for future studies and we anticipate that it will contribute to the development of a new drug in cancer treatment.